La Ville du Bois, France

Arnaud Chevalier


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Bruere Allichanps, FR (2019)
  • La ville-du-Bois, FR (2020 - 2021)
  • Bruere Allichamps, FR (2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Arnaud Chevalier

Introduction

Arnaud Chevalier is a notable inventor based in La Ville du Bois, France. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with various applications. With a total of four patents to his name, Chevalier's work focuses on innovative solutions that address specific scientific challenges.

Latest Patents

Chevalier's latest patents include "Substituted pyrimidine compounds as multifunctional radical quenchers and their uses." This invention provides compounds with a general formula that includes pharmaceutically acceptable salts, along with methods for using these compounds and compositions. Another significant patent is "Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting." This invention relates to prodrugs that are susceptible to nitroreductase (NTR) activation, offering mitochondria-targeting prodrug compounds and probes for imaging and therapeutic delivery.

Career Highlights

Arnaud Chevalier is affiliated with Arizona State University, where he continues to advance his research and innovation in the field of chemistry. His work has garnered attention for its potential applications in pharmaceuticals and medical imaging.

Collaborations

Chevalier has collaborated with esteemed colleagues such as Sidney M Hecht and Omar Khdour, contributing to a rich environment of innovation and research.

Conclusion

Arnaud Chevalier's contributions to the field of chemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic and imaging technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…